Ozone therapy shows promise in treating sepsis-induced lung injury

Sepsis, a severe and often fatal complication of infection, is a leading cause of both ALI and acute respiratory distress syndrome (ARDS).

Sanofi eyes RSV antibody for its next blockbuster while Dupixent brings in record sales

Sanofi’s RSV antibody Beyfortus is still on track to reach blockbuster status this year as the company expands manufacturing capacity, according to remarks made Thursday

July 26, 2024

FDA Allows Best-Selling E-Cigarette Vuse Alto, but Only in Tobacco Flavor

The FDA on Thursday authorized sales of the best-selling e-cigarette in the U.S., Vuse Alto, allowing manufacturer Reynolds American to keep the vaping brand on

July 19, 2024

Market cap upturn for top 20 biopharma companies with obesity drug successes in 2023 – Pharmaceutical Technology

Share this article Figure 1: Top 20 global biopharmaceutical companies, by market cap, as of 31 December 2023. Source: GlobalData, Pharma Intelligence Center, Stock Exchanges,

March 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.